Antheia Receives Phase I SBIR Award from the National Institute of Drug Abuse to Make Non-Addict...

The objective of this Phase I SBIR project will be to develop engineered yeast strains that produce high levels of noroxymorphone, the direct precursor for the nal opioids naloxone and naltrexone through whole cell

biocatalysis.


Read more about the award: https://www.sbir.gov/sbirsearch/detail/1247101

0 comments